Cited by 373Cancer Genomics and DiagnosticsAdvanced biosensing and bioanalysis techniquesExtracellular vesicles in disease

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Isolation and characterization of DNA from the plasma of cancer patients

Stroun, Maurice, Anker, Philippe, Lyautey, Jacqueline, Lederrey, Christine, Maurice, Pierre A.·1987·European Journal of Cancer and Clinical Oncology

DOI 10.1016/0277-5379(87)90266-5

Open this paper in CoChat — free account

Abstract

Unlabelled Ten out of 37 patients with advanced malignant diseases were found to have extractable amounts of DNA in their plasma whereas no DNA could be detected in 50 normal controls. After its purification from the original nucleoprotein complex, DNA plasma levels ranging from 0.15 to 12 micrograms/ml were measured, the lowest concentration detectable with our method being 0.1 microgram/ml. Knowing from recovery experiments performed with 32P-DNA that the loss of DNA during the extraction procedure is about 65%, the real concentration of DNA in the plasma corresponds to about 3 times the given figures. The purified DNA was shown to be double-stranded and composed of fractions ranging from 21 kb to less than 0.5 kb, as determined by agarose gel electrophoresis. All these fractions hybridized with a 32P-labelled human DNA probe indicating the human origin of the bulk of the circulating DNA.In conclusion the finding of extractable amounts of DNA in the plasma of 27% of the investigated cancer patients, and its absence from the controls, suggests some correlation with malignancy.

Integrity signals

Registry

Crossref · 10.1016/0277-5379(87)90266-5

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. R. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,400
Untitled work
(1977) · PubMed · Cited by 1,801
Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system.
Anker, P., Stroun, M., & Maurice, P. A. (1975) · PubMed · Cited by 234
Self-citation
Excretion of Deoxyribonucleic Acid by Lymphocytes Stimulated with Phytohemagglutinin or Antigen
ROGERS, J. C., Boldt, D. H., Kornfeld, S. A., Skinner, S. A. M., & VALERI, C. R. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.7.1685 · Cited by 158
Circulating Nucleic Acids in Higher Organisms
Stroun, M., Anker, P., Maurice, P. A., & Gahan, P. B. (1977) · International review of cytology · doi:10.1016/s0074-7696(08)60225-9 · Cited by 106
Self-citation
Circulating DNA in systemic lupus erythematosus. Isolation and characterization.
Steinman, C. R. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111278 · Cited by 99
Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans.
Wieczorek, A. J., Rhyner, C., & Block, L. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.10.3455 · Cited by 97
Circulating DNA in systemic lupus erythematosus
Steinman, C. R. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90789-7 · Cited by 95
Cell-surface-associated nucleic acid in tumorigenic cells made visible with platinum-pyrimidine complexes by electron microscopy.
Aggarwal, S. K., Wagner, R. W., McAllister, P. K., & Rosenberg, B. H. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.928 · Cited by 79
Nucleic acids spontaneously released by living frog auricles
Stroun, M., & Anker, P. (1972) · Biochemical Journal · doi:10.1042/bj1280100pb · Cited by 69
Self-citation

Show all 17 references

Research works printed but not linked: 1

Carpentier, 1981, The presence of circulating DNA in patients with acute or chronic leukemia: relation to serum anti-DNA antibodies and Clq binding activity, Human Lymphocyte Differentiation, 1, 93

Sorted by citations

Items 101–200 of 371

Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies
Abbou, S. D., Shulman, D. S., DuBois, S. G., & Crompton, B. D. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27595 · Cited by 72
Detection and identification of plasma bacterial and viral elements in HIV/AIDS patients in comparison to healthy adults
Li, S.-K., Leung, R. K., Guo, H., Wei, J., Wang, J.-H., Kwong, K.-S., Lee, S.-S., Zhang, C., & Tsui, S. K. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03690.x · Cited by 73
The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins
Felekkis, K. N., & Papaneophytou, C. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063403 · Cited by 73
Dielectrophoretic isolation of DNA and nanoparticles from blood
Sonnenberg, A., Marciniak, J. Y., Krishnan, R., & Heller, M. J. (2012) · Electrophoresis · doi:10.1002/elps.201100700 · Cited by 71
Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue.
García-Olmo, D. C., Ruiz-Piqueras, R., & García‐Olmo, D. (2004) · PubMed · doi:10.14670/hh-19.575 · Cited by 71
Rearranged Ig Heavy Chain DNA Is Detectable in Cell-Free Blood Samples of Patients With B-Cell Neoplasia
Frickhofen, N., Müller, E., Sandherr, M., Binder, T. M., Bangerter, M., Wiest, C., Enz, M., & Heimpel, H. (1997) · Blood · doi:10.1182/blood.v90.12.4953 · Cited by 70
Cell‐free tumour DNA testing for early detection of cancer – a potential future tool
Barbany, G., Arthur, C., Liedén, A., Nordenskjöld, M., Rosenquist, R., Tesi, B., Wallander, K., & Tham, E. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12897 · Cited by 73
Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies
Yang, H., Yang, K. Y., AL.-Khafagi, A. A., Tang, Y., Carey, T. E., Opipari, A. W., Lieberman, R. W., Oeth, P. A., Lancaster, W. D., Klinger, H. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406904102 · Cited by 69
Complete Genes May Pass from Food to Human Blood
Spisák, S., Solymosi, N., Ittzés, P., Bodor, A., Kondor, D., Vattay, G., Barták, B. K., Sípos, F., Galamb, O., Tulassay, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069805 · Cited by 69
Preconcentration of DNA using magnetic ionic liquids that are compatible with real-time PCR for rapid nucleic acid quantification
Emaus, M. N., Clark, K. D., Hinners, P., & Anderson, J. L. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1092-9 · Cited by 67
Measurement of Circulating Cell-Free DNA Levels by a Simple Fluorescent Test in Patients With Breast Cancer
Agassi, R., Czeiger, D., Shaked, G., Avriel, A., Sheynin, J., Lavrenkov, K., Ariad, S., & Douvdevani, A. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcpi5yhg0ogfahm · Cited by 66
Circulating free tumor DNA in non-small cell lung cancer (NSCLC): clinical application and future perspectives
Herbreteau, G., Vallée, A., Charpentier, S., Normanno, N., Hofman, P. M., & Denis, M. G. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.12.18 · Cited by 65
Circulating Nucleic Acids and Proteomics of Plasma/Serum: Clinical Utility
Taback, B., & Hoon, D. S. �. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.002 · Cited by 64
Improved Method for Isolating Cell-Free DNA
Schmidt, B., Weickmann, S., Witt, C. C., & Fleischhacker, M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.051003 · Cited by 63
Fe–Au Nanoparticle‐Coupling for Ultrasensitive Detections of Circulating Tumor DNA
Hu, P., Zhang, S., Wu, T. S., Ni, D., Fan, W., Zhu, Y. Q., Qian, R., & Shi, J. (2018) · Advanced Materials · doi:10.1002/adma.201801690 · Cited by 64
Circulating free tumor DNA and colorectal cancer
Lecomte, T., Cézé, N., Dorval, E. D., & Laurent‐Puig, P. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2009.04.015 · Cited by 59
Promises and pitfalls of multi-cancer early detection using liquid biopsy tests
Wan, J. C. M., Sasieni, P. D., & Rosenfeld, N. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01033-x · Cited by 69
Detection of tumor‐specific DNA in blood and bone marrow plasma from patients with prostate cancer
Schwarzenbach, H., Chun, F. K. ‐., Lange, I., Carpenter, S. W., Gottberg, M., Erbersdobler, A., Friedrich, M. G., Huland, H., & Pantel, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22470 · Cited by 58
Circulating nucleic acids in cancer and pregnancy
Pinzani, P., Salvianti, F., Pazzagli, M., & Orlando, C. (2010) · Methods · doi:10.1016/j.ymeth.2010.02.004 · Cited by 57
Screening and Early Detection of Lung Cancer
Westeinde, S. C. V. ‘., & van Klaveren, R. J. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e3182099319 · Cited by 56
Epigenetic markers of prostate cancer in plasma circulating DNA
Cortese, R., Kwan, A., Lalonde, E., Bryzgunova, O. E., Bondar, A. A., Wu, Y., Gordevičius, J., Park, M., Oh, G., Kaminsky, Z. A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds192 · Cited by 58
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook
Ng, C. K. Y., Costanzo, G. G. D., Terracciano, L., & Piscuoglio, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00078 · Cited by 57
The potential of circulating cell free RNA as a biomarker in cancer
Cheung, K. W. E., Choi, S.-Y. R., Lee, L. T. C., Lee, N. L. E., Tsang, H. F., Cheng, Y., Cho, W. C. S., Wong, E. Y. L., & Wong, S. C. C. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1633307 · Cited by 57
Diagnostic liquid biopsy biomarkers in renal cell cancer
Zieren, R. C., Zondervan, P. J., Pienta, K. J., Bex, A., de Reijke, T. M., & Bins, A. D. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00818-y · Cited by 55
Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy – A study with monozygotic twin pairs
Kangas, R., Pöllänen, E., Rippo, M. R., Lanzarini, C., Prattichizzo, F., Niskala, P., Jylhävä, J., Sipilä, S., Kaprio, J. A., Procopio, A. D., et al. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.11.001 · Cited by 54
Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era
Brothers, J. F., Hijazi, K., Mascaux, C., El‐Zein, R. A., Spitz, M. R., & Spira, A. E. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-168 · Cited by 53
Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker
Rohanizadegan, M. (2018) · Cancer Genetics · doi:10.1016/j.cancergen.2018.02.002 · Cited by 54
Low Correspondence Between K-ras Mutations in Pancreatic Cancer Tissue and Detection of K-ras Mutations in Circulating DNA
Marchese, R., Muleti, A., Pasqualetti, P., Bucci, B., Stigliano, A., Brunetti, E., Angelis, M. D., Mazzoni, G., Tocchi, A., & Brozzetti, S. (2006) · Pancreas · doi:10.1097/01.mpa.0000202938.63084.e3 · Cited by 53
Circulating and imaging markers for angiogenesis
Pathak, A. P., Hochfeld, W. E., Goodman, S. L., & Pepper, M. S. (2008) · Angiogenesis · doi:10.1007/s10456-008-9119-z · Cited by 50
Current status of non‐invasive prenatal testing in Japan
Samura, O., Sekizawa, A., Suzumori, N., Sasaki, A., Wada, S., Hamanoue, H., Hirahara, F., Sawai, H., Nakamura, H., Yamada, T., et al. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13373 · Cited by 51
Cell‐free DNA is released from tumor cells upon cell death: A study of tissue cultures of tumor cell lines
Li, C., Hsu, H., Wu, T., Tsao, K., Sun, C., & Wu, J. T. (2003) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.10081 · Cited by 51
Advances in Directly Amplifying Nucleic Acids from Complex Samples
Walker, F. M., & Hsieh, K. (2019) · Biosensors · doi:10.3390/bios9040117 · Cited by 51
Plasma nucleosome levels in node-negative breast cancer patients
Kuroi, K., Tanaka, C., & Toi, M. (1999) · Breast Cancer · doi:10.1007/bf02966454 · Cited by 49
Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate Cancer
Schütz, E., Akbari, M. R., Beck, J., Urnovitz, H. B., Zhang, W., Bornemann-Kolatzki, K., Mitchell, W. M., Nam, R. K., & Narod, S. A. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.226571 · Cited by 50
Circulating DNA in Plasma and Serum: Biology, Preanalytical Issues and Diagnostic Applications
Lui, Y. Y.-N., & Lo, Y. M. D. (2002) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2002.169 · Cited by 48
Size distribution of cell-free DNA in oncology
Udomruk, S., Orrapin, S., Pruksakorn, D., & Chaiyawat, P. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103455 · Cited by 49
Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis
Tóth, K., Barták, B. K., Tulassay, Z., & Molnar, B. A. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1132164 · Cited by 47
Liquid biopsy: unlocking the potentials of cell-free DNA
Chu, D. T. W., & Park, B. H. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2137-8 · Cited by 50
Quantitative Analysis of Plasma TP53 249Ser-Mutated DNA by Electrospray Ionization Mass Spectrometry
LLeonart, M. E., Kirk, G. D., Villar, S., Lesi, O. A., Dasgupta, A., Goedert, J. J., Mendy, M. E., Hollstein, M. C., Montesano, R., Groopman, J. D., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0612 · Cited by 47
Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients.
Chiang, P. W., Beer, D. G., Wei, W. L., Orringer, M. B., & Kurnit, D. M. (1999) · PubMed · Cited by 47
Integrity of Cell‐Free Plasma DNA in Patients with Lung Cancer and Nonmalignant Lung Disease
Schmidt, B., Weickmann, S., Witt, C. C., & Fleischhacker, M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.034 · Cited by 46
An Improved Method for the Isolation of Free‐Circulating Plasma DNA and Cell‐Free DNA from Other Body Fluids
Kirsch, C., Weickmann, S., Schmidt, B., & Fleischhacker, M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.035 · Cited by 46
Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors
Aghamir, S. M. K., Heshmat, R., Ebrahimi, M., & Khatami, F. (2020) · Epigenetics Insights · doi:10.1177/2516865720904052 · Cited by 47
Tumor circulating DNA profiling in xenografted mice exposed to intermittent hypoxia
Cortese, R., Almendros, I., Wang, Y., & Gozal, D. (2014) · Oncotarget · doi:10.18632/oncotarget.2785 · Cited by 46
Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids
Lewis, J. M., Heineck, D. P., & Heller, M. J. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1069709 · Cited by 44
A historical and evolutionary perspective on the biological significance of circulating DNA and extracellular vesicles
Aucamp, J., Bronkhorst, A. J., Badenhorst, C. P. S., & Pretorius, P. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2370-3 · Cited by 44
Diagnostic accuracy of Mycobacterium tuberculosis cell-free DNA for tuberculosis: A systematic review and meta-analysis
Yu, G., Shen, Y., Ye, B., & Shi, Y. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253658 · Cited by 42
Environmentally induced ribosomal DNA (rDNA) instability in human cells and populations exposed to hexavalent chromium [Cr (VI)]
Lou, J., Yu, S., Feng, L., Guo, X., Wang, M., Branco, A. T., Li, T., & Lemos, B. (2021) · Environment International · doi:10.1016/j.envint.2021.106525 · Cited by 42
Detection of DNA in the Plasma of Septic Patients
MARTINS, G. A., Kawamura, M. T., & Carvalho, M. D. G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06603.x · Cited by 42
LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival
Kuhlmann, J. D., Schwarzenbach, H., Wimberger, P., Poetsch, M., Kimmig, R., & Kasimir‐Bauer, S. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-325 · Cited by 42
Identification of Loss of Heterozygosity on Circulating Free DNA in Peripheral Blood of Prostate Cancer Patients: Potential and Technical Improvements
Müller, I., Beeger, C., Alix‐Panabières, C., Rébillard, X., Pantel, K., & Schwarzenbach, H. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.099333 · Cited by 42
Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth
Tedcastle, A. B., Illingworth, S., Brown, A., Seymour, L. W., & Fisher, K. D. (2015) · Molecular Therapy · doi:10.1038/mt.2015.233 · Cited by 42
Tumor-Based Genetic Testing and Familial Cancer RiskPreprint
Forman, A. D., & Sotelo, J. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036590 · Cited by 42
Circulating Tumor DNA and Hepatocellular Carcinoma
Yang, J. D., Liu, M., & Kisiel, J. B. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1688503 · Cited by 40
Prognostic biomarkers in ovarian cancer
Huang, J., Hu, W., & Sood, A. K. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0212 · Cited by 42
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours
Aung, K. L., R. E. Board, Ellison, G., Donald, E. L., Ward, T. H., Clack, G., Ranson, M., Hughes, A. M., Newman, W. G., & Dive, C. (2010) · The HUGO Journal · doi:10.1007/s11568-011-9149-2 · Cited by 41
Molecular methods for the diagnosis of cancer
Cairns, P., & Sidransky, D. (1999) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00006-2 · Cited by 39
Blood-Based Biomarkers for Managing Workload in Athletes: Perspectives for Research on Emerging Biomarkers
Haller, N., Reichel, T., Zimmer, P., Behringer, M., Wahl, P., STÖGGL, T. L., Krüger, K., & Simon, P. D. (2023) · Sports Medicine · doi:10.1007/s40279-023-01866-5 · Cited by 44
Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients
Balañá, C., Carrato, C., Ramírez, J. L., Cardona, A. F., Berdiel‐Acer, M., Sánchez, J. J., Tarón, M., Hostalot, C., Musulén, E., Ariza, A., et al. (2011) · Clinical & Translational Oncology · doi:10.1007/s12094-011-0714-x · Cited by 37
Tumor-related alterations in circulating DNA, potential for diagnosis, prognosis and detection of minimal residual disease
Anker, P., & Stroun, M. (2001) · Leukemia · doi:10.1038/sj.leu.2402016 · Cited by 37
Self-citation
Circulating Tumor Cells and Circulating Tumor DNA
Lianidou, E. S., & Hoon, D. S. �. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-816061-9.00009-6 · Cited by 36
Nurturing the marriages of urinary liquid biopsies and nano‐diagnostics for precision urinalysis of prostate cancer
Liao, C., Wu, Z., Lin, C., Chen, X., Zou, Y., Wan, Z., Li, X., Huang, G., Xu, B., Briganti, G. E., et al. (2023) · Smart Medicine · doi:10.1002/smmd.20220020 · Cited by 36
Quantitative Aspects of Plasma/Serum DNA in Cancer Patients
Anker, P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06580.x · Cited by 36
Self-citation
New insights into nucleic acid sensor AIM2: The potential benefit in targeted therapy for cancer
Cui, J.-Z., Chew, Z. H., & Lim, L. H. K. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107079 · Cited by 36
The Omics Revolution Continues: The Maturation of High-Throughput Biological Data Sources
Mathé, E. A., Hays, J. L., Stover, D. G., & Chen, J. L. (2018) · Yearbook of Medical Informatics · doi:10.1055/s-0038-1667085 · Cited by 33
Recent Advances in Liquid Biopsy in Precision Oncology Research
Sato, Y., Matoba, R., & Kato, K. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00804 · Cited by 35
Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats
Garcı́a-Olmo, D. C., Picazo, M. G., Toboso, I., Asensio, A. I., & García‐Olmo, D. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-8 · Cited by 34
Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma
Eskandari, M. A., Manoochehrabadi, S., Pashaiefar, H., Zaimy, M. A., & Ahmadvand, M. (2019) · Blood Research · doi:10.5045/br.2019.54.2.114 · Cited by 34
Expanding detection windows for discriminating single nucleotide variants using rationally designed DNA equalizer probes
Wang, G. A., Xie, X., Mansour, H. H., Chen, F., Matamoros, G., Sanchez, A. L., Fan, C., & Li, F. (2020) · Nature Communications · doi:10.1038/s41467-020-19269-9 · Cited by 36
Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia
Schwarz, A. K., Stanulla, M., Cario, G., Flohr, T., Sutton, R., Möricke, A., Anker, P., Stroun, M., Welte, K., Bartram, C. R., et al. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0698-6 · Cited by 34
Self-citation
An AC electrokinetic method for enhanced detection of DNA nanoparticles
Krishnan, R., & Heller, M. J. (2009) · Journal of Biophotonics · doi:10.1002/jbio.200910007 · Cited by 33
Circulating Cell-Free DNA as a Prognostic and Molecular Marker for Patients with Brain Tumors under Perillyl Alcohol-Based Therapy
Faria, G. M., Silva, E., Fonseca, C. D., & Quírico‐Santos, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061610 · Cited by 33
Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies
Mamtimin, M., Pinarci, A., Han, C., Braun, A., Anders, H., Gudermann, T. W., & Mammadova‐Bach, E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.869706 · Cited by 35
Circulating Cell-Free Nucleic Acids: Promising Biomarkers of Hepatocellular Carcinoma
Zhou, J., Shi, Y., & Fan, J. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.013 · Cited by 33
Genomic Profiling of Circulating Plasma RNA for the Analysis of Cancer
Collado, M., García‐Barberán, V., Garcia, J. M., Alonso, I., Lombardía, L., Díaz‐Uriarte, R., López-Fernández, L. A., Zaballos, Á., Bonilla, F., & Serrano, M. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.089201 · Cited by 33
Microsatellite abnormalities in plasma of patients with breast carcinoma: concordance with the primary tumour.
Mayall, F. G., Fairweather, S. M., Wilkins, R., Chang, B., & Nicholls, R. J. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.5.363 · Cited by 33
Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung Cancer
Pellini, B., Szymanski, J. J., Chin, R.-I., Jones, P. A., & Chaudhuri, A. A. (2020) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2020.01.005 · Cited by 32
Current therapy of advanced colorectal cancer according to RAS/RAF mutational status
Lakatos, G., Köhne, C., & Bodoky, G. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09913-7 · Cited by 31
Detection of circulating tumor cells and of tumor DNA in plasma during tumor progression in rats
Garcı́a-Olmo, D. C., Gutiérrez-González, L., Ruiz-Piqueras, R., Picazo, M. G., & García‐Olmo, D. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.043 · Cited by 32
Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
Taback, B., Giuliano, A. E., Hansen, N. M., Singer, F. R., Shu, S. T., & Hoon, D. S. �. (2003) · PubMed · Cited by 30
Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome
Romanet, P., Philibert, P., Fina, F., Cuny, T., Roche, C., Ouafik, L., Paris, F., Reynaud, R., & Barlier, A. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.09.070 · Cited by 33
Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma
Nakatsuka, T., Nakagawa, H., Hayata, Y., Wake, T., Yamada, T., Kinoshita, M. N., Nakagomi, R., Sato, M., Minami, T., Uchino, K., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01773-4 · Cited by 30
Low‐Molecular‐Weight DNA in Blood Plasma as an Index of the Influence of Ionizing Radiation
Vasilyeva, I. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03889.x · Cited by 29
Detection of K-rasPoint Mutations in the Supernatants of Peritoneal and Pleural Effusions for Diagnosis Complementary to Cytologic Examination
Yamashita, K., Kuba, T., Shinoda, H., Takahashi, E., & Okayasu, I. (1998) · American Journal of Clinical Pathology · doi:10.1093/ajcp/109.6.704 · Cited by 29
Microsatellite Alterations Detected in the Serum of Early Stage Breast Cancer Patients
Taback, B., Giuliano, A. E., Hansen, N. M., & Hoon, D. S. �. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03860.x · Cited by 29
CirculatingBRAFV600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma
Iyer, P. C., Cote, G. J., Hai, T., Gule-Monroe, M. K., Bui, J. H., Williams, M. D., Hess, K. R., Hofmann, M.-C. C., Dadu, R., Zafereo, M., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.18.00173 · Cited by 28
Potential clinical applications of circulating cell-free DNA in ovarian cancer patients
Barbosa, A. P. F., Peixoto, A., Pinto, P., Pinheiro, M., & Teixeira, M. R. (2018) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2018.5 · Cited by 27
Molecular Biomarkers for Cancer Detection in Blood and Bodily Fluids
Feng, Q., Yu, M., & Kiviat, N. B. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360600922632 · Cited by 28
Cancer and mutant DNA in blood plasma
Mulcahy, H. E., Croke, D. T., & Farthing, M. J. G. (1996) · The Lancet · doi:10.1016/s0140-6736(05)65067-2 · Cited by 27
Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology
Tan, W. Y., Nagabhyrava, S., Ang-Olson, O., Das, P., Ladel, L., Sailo, B., He, L., Sharma, A. R., & Ahuja, N. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46070390 · Cited by 28
Circulating cell-free DNA is predominantly composed of retrotransposable elements and non-telomeric satellite DNA
Grabuschnig, S., Soh, J., Heidinger, P., Bachler, T., Hirschböck, E., Rodriguez, I. R., Schwendenwein, D., & Sensen, C. W. (2020) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2020.03.002 · Cited by 26
Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies
Leick, K. M., Kazarian, A. G., Rajput, M., Tomanek‐Chalkley, A., Miller, A., Shrader, H. R., McCarthy, A., Coleman, K. L., Kasi, P. M., & Chan, C. H. F. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08832-9 · Cited by 26
Further the liquid biopsy: Gathering pieces of the puzzle of genometastasis theory
García‐Casas, A., Garcı́a-Olmo, D. C., & García‐Olmo, D. (2017) · World Journal of Clinical Oncology · doi:10.5306/wjco.v8.i5.378 · Cited by 25
Liquid biopsies in pediatric oncology: opportunities and obstacles
Sundby, R. T., Pan, A. C., & Shern, J. F. (2021) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001088 · Cited by 26
Near infrared Raman spectroscopic characterization of blood plasma of normal, oral premalignant and malignant conditions—a pilot study
Pachaiappan, R., Aruna, P., Bharanidharan, G., Koteeswaran, D., Baludavid, M., & Ganesan, S. (2015) · Journal of Raman Spectroscopy · doi:10.1002/jrs.4693 · Cited by 25
The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring
Openshaw, M. R., Page, K., Fernández-García, D., Guttery, D. S., & Shaw, J. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1184974 · Cited by 27
PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma
Morikawa, A., Hayashi, T., Shimizu, N., Kobayashi, M., Taniue, K., Takahashi, A., Tachibana, K., Saito, M., Kawabata, A., Iida, Y., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24555 · Cited by 25
Mutations of p53 gene can be detected in the plasma of patients with large bowel carcinoma.
Mayall, F. G., Jacobson, G. M., Wilkins, R., & Chang, B. (1998) · Journal of Clinical Pathology · doi:10.1136/jcp.51.8.611 · Cited by 25
The concentration of deoxyribonucleic acid in plasma from 73 patients with colorectal cancer and apparent clinical correlations
Guadalajara, H., Domínguez–Berzosa, C., García‐Arranz, M., Herreros, M. D., Pascual, I., Baro, R. S., Garcı́a-Olmo, D. C., & García‐Olmo, D. (2008) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2008.01.002 · Cited by 24
Genomic DNA extraction from small amounts of serum to be used for α1-antitrypsin genotype analysis
Andolfatto, S., Namour, F., Garnier, A.-R., Chabot, F., Guéant, J., & Aimone‐Gastin, I. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00044303 · Cited by 24

Authors: Stroun, M., Anker, P., Lyautey, J., Lederrey, C., & Maurice, P. A.
Affiliations: University of Geneva (CH)
University Hospital of Geneva (CH)
Venue: European Journal of Cancer and Clinical Oncology
Publisher: Elsevier BV
Published: 1987-06
Volume: 23
Issue: 6
Pages: 707-712
ISSN: 0277-5379 (ISSN-L)
DOI: 10.1016/0277-5379(87)90266-5
OpenAlex: W2058440954
Cited by: 373
References: 17
Citations by year: 2026: 8 · 2025: 9 · 2024: 7 · 2023: 18 · 2022: 16 · 2021: 21 · 2020: 21 · 2019: 29 · 2018: 27 · 2017: 13 · 2016: 13 · 2015: 10 · 2014: 15 · 2013: 11 · 2012: 18
FWCI: 0.00
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: European Journal of Cancer and Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords: circulating tumor DNA, plasma DNA, cancer patients, DNA extraction, DNA purification, double-stranded DNA, DNA fragment size distribution, DNA hybridization, malignancy marker
MeSH terms: DNA, Neoplasm, Electrophoresis, Agar Gel, Humans, Neoplasms, Nucleic Acid Hybridization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Isolation and characterization of DNA from the plasma of cancer patients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks